The field of biotechnology has undergone some of the most sweeping changes in recent times and has had far-reaching impact both on our quality of life and on other areas of technology. Still, the biotechnology sector requires heavy investment that can take a long time to bear fruit. Often only solid industrial property rights that ensure exclusive entitlement to market the resulting products will encourage companies to set out on the path that will eventually lead to market. In view of the special nature of biotechnology inventions in terms of both the requirements for protection and differences in legislation in the different countries, being able to secure the corresponding rights will often depend on obtaining proper advice for selecting subject matter for patenting, drafting and prosecuting patents, and negotiating licences.
ELZABURU has a multidisciplinary team of experienced patent attorneys who specialize in the field of biotechnology and can provide across-the-board advice for both obtaining protection for inventions and negotiating licenses and other business arrangements.
The possibility of patenting human parthenotes. Judgment of the Court of Justice of 18 December 2014, International Stem Cell Corporation (C-364/13)
Commentary of the case C-364/13 on the legal protection of biotechnological inventions and the concept of human embryo.
Tomatoes and broccoli: products obtained by essentially biological processes are patentable
Spring has sprung and has brought with it two important decisions concerning plants, Decisions G2/12 (Tomatoes II) and G2/13 (Broccoli II) by the Enlarged Board of Appeals of the European Patent Office (EPO).
Patent protection and transfer of technology in biotech
Protection by patent is very important for biotechnology innovations to facilitate transfer of technology.
ELZABURU to take part in The BIO Convention in China
ELZABURU China Director, Marcos García, will attend "The BIO Convention" held in Beijing until the 13rd November.
Biotechnology patents: Court of Justice of the European Union sets limits in case C-428/08
The Court of Justice of the European Union has recently considered the scope of protection afforded to biotechnological inventions in the Monsanto case (C-428/08).
No video content currently available.